DJIA 17,712.66 34.43 0.19%
NASDAQ 4,891.22 27.86 0.57%
S&P 500 2,061.02 4.87 0.24%
market minute promo

Nektar Therapeutics (NASDAQ: NKTR)



company name or ticker

Sector Update: Health-Care Stocks Mixed Pre-Market

Nektar Therapeutics (NKTR) Shares Cross Below 200 DMA

Salix' s Xifaxan 550 sNDA Under Review, Response by Feb 28 - Analyst Blog

Salix' s Xifaxan 550 sNDA Under Review, Response by Feb 28 - Analyst Blog

Nektar Presents Positive Preclinical Data On Oral, Peripherally-Acting Kappa Agonist Molecules At 20

Nektar Presents Positive Preclinical Data On Oral, Peripherally-Acting Kappa Agonist Molecules At 2014 American Academy Of Pain Management Meeting

AstraZeneca's Constipation Drug Movantik Gets FDA Nod - Analyst Blog

How Will AstraZeneca (AZN) and Nektar Therapeutics (NKTR) Stock Reacy to FDA's Movantik Approval?

Nektar 181 Could Dominate A $13B Chronic Pain Market

Monday's ETF Movers: FBT, GDX

Positive Data on Baxter's Trial for BAX 855 - Analyst Blog

Positive Data on Baxter's Trial for BAX 855 - Analyst Blog

Nektar Therapeutics Has More To Give

See More Articles...